Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Receivables - Other (2023 - 2025)

Historic Receivables - Other for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $79000.0.

  • Artiva Biotherapeutics' Receivables - Other fell 4015.15% to $79000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $79000.0, marking a year-over-year decrease of 4015.15%. This contributed to the annual value of $146000.0 for FY2024, which is 7983.43% down from last year.
  • Artiva Biotherapeutics' Receivables - Other amounted to $79000.0 in Q3 2025, which was down 4015.15% from $30000.0 recorded in Q2 2025.
  • Over the past 5 years, Artiva Biotherapeutics' Receivables - Other peaked at $892000.0 during Q2 2024, and registered a low of $30000.0 during Q2 2025.
  • In the last 3 years, Artiva Biotherapeutics' Receivables - Other had a median value of $146000.0 in 2024 and averaged $319571.4.
  • Over the last 5 years, Artiva Biotherapeutics' Receivables - Other had its largest YoY gain of 4015.15% in 2025, and its largest YoY loss of 9663.68% in 2025.
  • Over the past 3 years, Artiva Biotherapeutics' Receivables - Other (Quarter) stood at $724000.0 in 2023, then plummeted by 79.83% to $146000.0 in 2024, then crashed by 45.89% to $79000.0 in 2025.
  • Its last three reported values are $79000.0 in Q3 2025, $30000.0 for Q2 2025, and $234000.0 during Q1 2025.